CCDC12 has been demonstrated to accelerate the growth of K562 cells by upregulating CD235, ε-globin, and γ-globin in human chronic myeloid leukemia [8]. This evidence concerns the gene CCDC12 and chronic myelogenous leukemia, BCR-ABL1 positive.